LanZhou Foci Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 607.75 million compared to CNY 460.32 million a year ago. Revenue was CNY 609.03 million compared to CNY 461.79 million a year ago.

Net income was CNY 57.05 million compared to CNY 51.24 million a year ago. Basic earnings per share from continuing operations was CNY 0.1117 compared to CNY 0.1007 a year ago. Diluted earnings per share from continuing operations was CNY 0.1117 compared to CNY 0.1007 a year ago.